1791P Effect of anlotinib in advanced small cell lung cancer (SCLC) patients with liver metastases: A subgroup analysis from a randomized, double-blind phase II trial (ALTER 1202).

Authors :: Cheng, Y.
Wang, Q.
Li, K.
Shi, J.
Wu, L.
Han, B.
Chen, G.
He, J.
Wang, J.
QIN, H.
Li, X.
Source :: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1038-S1038. 1p.
Publication Year :: 2020

Subjects :: *SMALL cell lung cancer
*LIVER metastasis
*SUBGROUP analysis (Experimental design)

Full Text Access

Tools